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Abstract
Conjugated fatty acid, the general term of positional and geometric isomers of polyunsaturated
fatty acids with conjugated double bonds, has attracted considerable attention because of its
potentially beneficial biological effects. In the present study, dietary effect of pomegranate seed oil
rich in punicic acid (9cis, 11trans, 13cis-conjugated linolenic acid; 9c, 11t, 13c-CLNA) on lipid
metabolism was investigated in obese, hyperlipidemic Otsuka Long-Evans Tokushima Fatty
(OLETF) rats. After 2 weeks feeding period, OLETF rats revealed obesity and hyperlipidemia
compared with their progenitor LETO rats. Feeding of the diet supplemented with 9% safflower oil
and 1% pomegranate seed oil (9c, 11t, 13c-CLNA diet) did not affect abdominal white adipose
tissue weights and serum lipid levels compared with the diet supplemented with 10% safflower oil
(control diet) in OLETF rats. However, the accumulated hepatic triacylglycerol was markedly
decreased by 9c, 11t, 13c-CLNA diet in OLETF rats. Activities of hepatic enzymes related to fatty
acid synthesis and fatty acid β-oxidation were not altered by 9c, 11t, 13c-CLNA diet. Levels of
monounsaturated fatty acid (MUFA), major storage form of fatty acid, in serum triacylglycerol were
markedly higher in obese, hyperlipidemic OLETF rats than in lean LETO rats. In addition, 9c, 11t,
13c-CLNA diet significantly decreased MUFA levels in OLETF rats. This is the first study showing
that 9c, 11t, 13c-CLNA suppresses delta-9 desaturation in vivo, and we suggest that the alleviation
of hepatic triacylglycerol accumulation by 9c, 11t, 13c-CLNA diet was, at least in part, attributable
to the suppression of delta-9 desaturation in OLETF rats.
Background
Conjugated fatty acid (CFA) is the general term of posi-
tional and geometric isomers of polyunsaturated fatty
acids with conjugated double bonds. It has been reported
that conjugated linoleic acid (CLA), the CFA form of lino-
leic acid, has favorable physiological effects, such as anti-
atherosclerosis, anti-obesity, anti-tumor, and anti-hyper-
tension [1-9]. There are also other types of CFA in some
plant seed oils. Punicic acid (9cis, 11trans, 13cis-conju-
gated linolenic acid; 9c, 11t, 13c-CLNA) is contained
about 72% in pomegranate seed oil [10]. α-Eleostearic
acid (9cis, 11trans, 13trans-CLNA) is contained in bitter
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gourd oil and tung seed oil about 60% and 70%, respec-
tively [10,11]. Catalpa seed oil also contains catalpic acid
(9trans, 11trans, 13cis-CLNA) about 31% and pot mari-
gold seed oil contains calendic acid (8trans, 10trans, 12cis-
CLNA) about 33% [10]. There are some studies showing
that mixtures of CLNA isomers, prepared by alkaline
isomerization of α-linolenic acid or plant seed oil, have
some physiological functions including body fat reduc-
tion and anti-tumor activity [12,13]. In addition, purified
α-eleostearic acid (9c, 11t, 13t-CLNA) and α-eleostearic
acid rich bitter gourd seed oil also reveal anti-carcinogen-
esis in vitro and in vivo [10,11,14,15]. However, there are
few studies evaluated the physiological function of
punicic acid (9c, 11t, 13c-CLNA) [10,16]. Previously, we
reported the hypolipidemic effect of purified punicic acid
in human liver derived HepG2 cells [17].
In the present study, we investigated the effects of pome-
granate seed oil rich in 9c, 11t, 13c-CLNA on lipid metab-
olism in Otsuka Long-Evans Tokushima fatty (OLETF)
rats. OLETF rats develop a syndrome with multiple meta-
bolic and hormonal disorders that shares many features
with human obesity [18-21]. OLETF rats have hyper-
phagia, because they lack receptors for cholecystokinin,
and become obese, developing hyperlipidemia, diabetes,
and hypertension. To clarify the physiological function of
9c, 11t, 13c-CLNA, we measured hepatic enzyme activities
in relation to lipid metabolism and fatty acid composition
in plasma of these obese, hyperlipidemic rats.
Results and Discussion
In comparison with their progenitor Long-Evans
Tokushima Otsuka (LETO) rats, OLETF rats had increased
body weight gain with enhanced food intake during 2
weeks feeding period (Table 1). In OLETF rats, food intake
was not different between the groups. There was also no
significant difference between groups in the relative liver
weights of LETO and OLETF rats. Food efficiency, how-
ever, was higher in 9c, 11t, 13c-CLNA group than in other
two groups. Chin et al. previously reported that CLA is a
growth factor for rats as shown by enhanced weight gain
and improved feed efficiency [22]. Thus, we consider that
9c, 11t, 13c-CLNA may have some growth promotional
function.
The effect of dietary 9c, 11t, 13c-CLNA on the accumula-
tion of abdominal white adipose tissue (WAT) was inves-
tigated (Figure 1). After 2 weeks feeding period, OLETF
rats developed marked abdominal obesity. Compared
with LETO rats, the control diet increased perirenal, epidi-
dymal, and omental WAT weights of OLETF rats to 2.6-,
1.5-, and 2.1-fold, respectively. There was no significant
effect of 9c, 11t, 13c-CLNA on the accumulation of
abdominal WAT in OLETF rats. However, 2 weeks feeding
of the diet supplemented with 5% pomegranate seed oil
resulted in a significant reduction of omental WAT weight
(by 27%) compared with the feeding of control diet in
OLETF rats (unpublished data). These results suggested
that 2 weeks feeding of 1% pomegranate seed oil diet
might not be enough to reveal anti-obese effect of 9c, 11t,
13c-CLNA.
After the 2 weeks feeding period, OLETF rats revealed
hyperlipidemia. Serum triacylglycerol, phospholipids,
and cholesterol levels of OLETF rats fed the control diet
were significantly higher than those of LETO rats fed the
control diet (Figure 2). However, feeding of 9c, 11t, 13c-
CLNA did not affect to serum lipid levels in OLETF rats.
Although the present results showing that dietary 1%
pomegranate seed oil rich in 9c, 11t, 13c-CLNA could not
alleviate hyperlipidemia in OLETF rats, our previous
report indicated that purified 9c, 11t, 13c-CLNA sup-
pressed the secretion of apolipoprotein B100 from
human liver derived HepG2 cells [17]. Further studies are
needed to elucidate the effect of purified 9c, 11t, 13c-
CLNA on the pathogenesis of hyperlipidemia in OLETF
rats.
Table 1: Effect of 9c, 11t, 13c-CLNA on body weight, relative liver weight, food intake, and food efficiency
LETO OLETF
Control 9c, 11t, 13c-CLNA
Body weight (g)
Initial 223 ± 3a 266 ± 12b 265 ± 8b
Final 282 ± 5a 357 ± 15b 369 ± 11b
Gain 59.4 ± 2.7a 91.3 ± 3.6b 104 ± 6b
Relative liver weight (g/100 g BW) 3.12 ± 0.09 3.40 ± 0.11 3.35 ± 0.06
Food intake (g) 17.8 ± 0.4a 25.8 ± 1.1b 26.2 ± 1.1b
Food efficiency (g BW gain/g intake) 25.7 ± 1.0a 27.3 ± 0.6b 30.4 ± 1.1b
a,bDifferent superscript letters show significant difference at P < 0.05.Lipids in Health and Disease 2004, 3:24 http://www.lipidworld.com/content/3/1/24
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Next, we investigated the effect of dietary 9c, 11t, 13c-
CLNA on the distribution of lipids to the liver. There was
no significant difference in relative liver weight between
control and 9c, 11t, 13c-CLNA group in OLETF rats. Pre-
vious reports indicated that CLA feeding resulted in the
development of hepatomegaly and fatty liver in mice [23-
25], and a mixture of CLNA also induced hepatic lipid
accumulation in rat [13]. In the present study, the triacylg-
lycerol concentration in OLETF rats was significantly
higher than that in LETO rats, and the triacylglycerol accu-
mulation in the liver of OLETF rats was markedly allevi-
ated by the 9c, 11t, 13c-CLNA diet (Figure 3). There was
no significant difference in liver phospholipids and cho-
lesterol levels among groups in LETO and OLETF rats.
These results suggest that 9c, 11t, 13c-CLNA has a preven-
tive effect against the triacylglycerol accumulation in the
liver.
To further investigate the regulation of hepatic lipid
metabolism, we analyzed the effect of dietary 9c, 11t, 13c-
CLNA on the activities of enzymes related to fatty acid
synthesis and fatty acid β-oxidation. As shown in Figure
4A, the activities of glucose-6-phosphate dehydrogenase
(G6PDH) and malic enzyme (ME), key enzymes of
NADPH production, and fatty acid synthase (FAS), a key
enzyme of fatty acid synthesis, were markedly increased in
OLETF rats fed the control diet compared with LETO rats.
There was no significant effect of dietary 9c, 11t, 13c-
CLNA on these enzyme activities in OLETF rats. The activ-
ities of carnitine palmitoyltransferase (CPT), a key
enzyme of fatty acid β-oxidation, and peroxisomal β-oxi-
dation were not different between OLETF and LETO rats,
and 9c, 11t, 13c-CLNA diet did not affect on these activi-
ties in OLETF rats (Figure 4B). Koba et al. previously
reported that a mixture of CLNA isomers, prepared by
alkaline isomerization, enhanced hepatic mitochondrial
and peroxisomal β-oxidation compared with linoleic acid,
α-linolenic acid, and CLA [13]. Thus, we consider that the
effect of 9c, 11t, 13c-CLNA on the fatty acid β-oxidation is
weak compared with those of other CLNA isomers. In
addition, the alleviation of hepatic triacylglycerol accu-
mulation by 9c, 11t, 13c-CLNA could not be attributed to
the regulation of enzyme activities related to the fatty acid
synthesis and fatty acid β-oxidation.
Effect of 9c, 11t, 13c-CLNA on abdominal white adipose tis- sue weight in LETO and OLETF rats Figure 1
Effect of 9c, 11t, 13c-CLNA on abdominal white adipose tis-
sue weight in LETO and OLETF rats. Rats were fed a control 
or 9c, 11t, 13c-CLNA diet for 2 weeks. Values are expressed 
as mean ± SE for 6 rats. a,bDifferent letters show significant 
differences at P < 0.05. Omen, omental; Peri, perirenal; Epi, 
epididymal.
Effect of 9c, 11t, 13c-CLNA on serum lipid levels in LETO  and OLETF rats Figure 2
Effect of 9c, 11t, 13c-CLNA on serum lipid levels in LETO 
and OLETF rats. Rats were fed a control or 9c, 11t, 13c-
CLNA diet for 2 weeks. Values are expressed as mean ± SE 
for 6 rats. a,bDifferent letters show significant differences at P 
< 0.05. TG, triacylglycerol; PL, phospholipids; Chol, 
cholesterol.Lipids in Health and Disease 2004, 3:24 http://www.lipidworld.com/content/3/1/24
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To gain insight into the effect of dietary 9c, 11t, 13c-CLNA
on lipid metabolism, we analyzed fatty acid composition
in serum triacylglycerol. As shown in Table 2, saturated
fatty acid (SFA) levels were lower and monounsaturated
fatty acid (MUFA) levels were higher in OLETF rats fed the
control diet than those in LETO rats. Feeding of 9c, 11t,
13c-CLNA significantly reduced MUFA levels in plasma
triacylglycerol of OLETF rats. It has been recognized that
MUFAs are the major fatty acid form in fat depots [26].
Alterations in the ratio of SFA to MUFA have been impli-
cated in various disease states including cardiovascular
disease, obesity, and diabetes [27-29]. Therefore, the ratio
of SFA to MUFA is of physiological importance in normal
and disease states. A key enzyme involved in the cellular
synthesis of MUFA from SFA is the membrane-bound
stearoyl-CoA desaturase (SCD), which inserts a cis-double
bond in the delta-9 position of fatty acid substrates. Previ-
ous reports indicated that 10t, 12c-CLA, an active isomer
of anti-obese effect of CLA, suppresses delta-9 desatura-
tion and SCD activity in vitro and in vivo [30-32]. In the
present study, the index of delta-9 desaturation, ratio of
oleic acid (18:1) versus stearic acid (18:0), was higher in
obese, hyperlipidemic OLETF rats compared with in lean
LETO rats, and it was significantly decreased by dietary 9c,
11t, 13c-CLNA in OLETF rats. As far as we know, this is the
first study showing that 9c, 11t, 13c-CLNA also suppresses
delta-9 desaturation in vivo. We suggest that the allevia-
tion of hepatic triacylglycerol accumulation by dietary 9c,
11t, 13c-CLNA was, at least in part, attributable to the sup-
pression of delta-9 desaturation in OLETF rats.
Conclusions
Dietary pomegranate seed oil rich in 9c, 11t, 13c-CLNA
alleviates hepatic triacylglycerol accumulation in obese,
hyperlipidemic OLETF rats. The mechanism of this effect
could not be attributed to the regulation of enzyme
activity related to fatty acid synthesis and fatty acid β-oxi-
dation. However, suppression of delta-9 desaturation by
dietary 9c, 11t, 13c-CLNA may be, at least in part,
involved this effect.
Materials and Methods
Animals and diets
All aspects of the experiment were conducted according to
the guidelines provided by the ethical committee of exper-
imental animal care at Saga University. Five weeks old
male OLETF rats and LETO rats, the progenitor of OLETF
rats, were provided by Tokusima Research Institute
(Otsuka Pharmaceutical, Tokushima, Japan). Rats were
housed individually in metal cages in temperature-con-
trolled room (24°C) under a 12-hour light/dark cycle.
After a 1-week adaptation period, OLETF rats were
assigned to two groups (six rats each) that were fed with a
semisynthetic diet supplemented with 10% safflower oil
(the control group) or a semisynthetic diet supplemented
with 9% safflower oil and 1% pomegranate seed oil rich
in 9cis, 11trans, 13cis-CLNA (the 9c, 11t, 13c-CLNA
group). LETO rats were fed the same diet as the OLETF rats
in the control group. The pomegranate seed oil rich in 9c,
11t, 13c-CLNA (69.0%) was prepared by Kaneka Co.
(Hyogo, Japan). The semisynthetic diet were prepared
according to recommendations of the AIN-76 [33] and
contained (in weight %): casein, 20; fat, 10; cornstarch,
15; vitamin mixture (AIN-76™), 1; mineral mixture (AIN-
76™), 3.5; DL-methionine, 0.3; choline bitartrate, 0.2; cel-
lulose, 5; and sucrose, 45. The rats received different diets
for 2 weeks and were killed by aortic exsanguinations
under diethyl ether anesthesia. Liver and abdominal (per-
irenal, epididymal, and omental) WATs were also excised
for analysis.
Analysis of lipids
Serum was separated by centrifuging the blood. Triacylg-
lycerol, cholesterol, and phospholipids in serum were
measured using enzyme assay kits from Wako Pure Chem-
icals (Tokyo, Japan). Liver lipids were extracted and puri-
fied according to the method of Folch et al [34]. The
concentrations of triacylglycerol, cholesterol, and phos-
Effect of 9c, 11t, 13c-CLNA on hepatic lipid levels in LETO  and OLETF rats Figure 3
Effect of 9c, 11t, 13c-CLNA on hepatic lipid levels in LETO 
and OLETF rats. Rats were fed a control or 9c, 11t, 13c-
CLNA diet for 2 weeks. Values are expressed as mean ± SE 
for 6 rats. a,bDifferent letters show significant differences at P 
< 0.05. TG, triacylglycerol; PL, phospholipids; Chol, 
cholesterol.Lipids in Health and Disease 2004, 3:24 http://www.lipidworld.com/content/3/1/24
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Effect of 9c, 11t, 13c-CLNA on activities of enzymes related to lipid metabolism, (A) G6PDH, ME, FAS (B) CPT, peroxisomal β- oxidation, in the liver of LETO and OLETF rats Figure 4
Effect of 9c, 11t, 13c-CLNA on activities of enzymes related to lipid metabolism, (A) G6PDH, ME, FAS (B) CPT, peroxisomal β-
oxidation, in the liver of LETO and OLETF rats. Rats were fed a control or 9c, 11t, 13c-CLNA diet for 2 weeks. Values are 
expressed as mean ± SE for 6 rats. a,bDifferent letters show significant differences at P < 0.05.
Table 2: Effect of 9c, 11t, 13c-CLNA on fatty acid composition in serum triacylglycerol.
LETO OLETF
Control 9c, 11t, 13c-CLNA
%
14:0 2.28 ± 0.23a 1.05 ± 0.15b 1.10 ± 0.13b
16:0 36.8 ± 0.7a 28.1 ± 0.7b 41.2 ± 2.7a
16:1 0.492 ± 0.066a 3.83 ± 0.25b 2.39 ± 0.20c
18:0 5.58 ± 0.63a 3.29 ± 0.26b 4.04 ± 0.32b
18:1 11.7 ± 0.7a 24.5 ± 1.4b 20.4 ± 1.4c
18:2 35.5 ± 0.7a 33.2 ± 0.9a 27.8 ± 1.4b
20:4 7.74 ± 0.76a 4.80 ± 0.40b 3.12 ± 0.44c
Desaturation index
∆9 desaturation 2.18 ± 0.24a 7.73 ± 0.83b 5.34 ± 0.75c
∆6 desaturation 0.219 ± 0.024a 0.144 ± 0.009b 0.110 ± 0.011b
a,b,cDifferent superscript letters show significant difference at P < 0.05.Lipids in Health and Disease 2004, 3:24 http://www.lipidworld.com/content/3/1/24
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pholipids were measured according to the methods of
Fletcher [35], Sperry and Webb [36], and Bartlett [37].
Measurement of fatty acid composition in plasma was car-
ried out as previously described [38,39].
Preparation of liver subcellular fractions
A piece of liver was homogenized in 6 volumes of a 0.25
M sucrose solution that contained 1 mM EDTA in a 10
mM tris Tris-HCL buffer (pH 7.4). Fractions of mitochon-
dria, microsomes, and cytosol were obtained as previ-
ously described[40]. The protein concentration was
determined according to the method of Lowry et al [41],
with bovine serum albumin used as the standard.
Assays of enzyme activity
The enzyme activities of ME (EC 1.1.1.40) [42], G6PDH
(EC1.1.1.49) [43], FAS (EC 2.3.1.85) [44] in the liver
cytosol fraction, mitochondrial CPT (EC2.3.1.23) [45]
and peroxisomal β-oxidation [46] were determined as
described.
Statistical analysis
All values are expressed as means ± SE. Data were analyzed
by one-way ANOVA, and all differences were inspected by
Duncan's new multiple-range test [47]. Differences were
considered to be significant at P<0.05.
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